* Practicing through a Law Corporation
News & Recognition
Jennifer A. Marles focuses her practice on helping clients develop and manage their intellectual property assets, particularly patents. Her focus is on clients in the life sciences space, including those involved in developing novel medical devices, chemical compositions, biologics and pharmaceuticals. She also assists clients to protect mechanical devices, and with contracts relating to their IP, including copyright and licensing issues relating to software. Jennifer also provides clients with opinions on issues such as patentability, trademark registrability, and freedom-to-operate.
Jennifer’s clients include a broad range of early stage and established companies and universities. She has helped her clients to patent inventions such as safety syringes, natural pesticides, new formulation technologies, and building components on a global basis. Jennifer has filed many provisional and PCT applications, and has assisted clients with optimizing their intellectual property protection strategy globally, including in China in conjunction with Chinese counsel.
She was awarded the Law Society Gold Medal for graduating at the top of her class in 2006 at the University of Victoria, and also received the J. Edward Maybee Memorial prize for earning the highest mark overall on the 2009 patent agent’s qualifying examination.
Starting her career in IP law with Oyen Wiggs as a summer student in 2004, Jennifer returned as an articled student in 2007, and then as an associate in 2008. She became a partner of the firm in 2015. Jennifer has served as an adjunct professor at the Peter A. Allard School of Law at the University of British Columbia since 2008, where she lectures on copyright law.
- IP counsel to a local medical device company throughout both the development of its IP portfolio and the due diligence involved in the offering for sale of that IP portfolio.
- IP counsel to a local chemical company engaged in the development of environmentally friendly pesticides and agrochemicals.
- Work with the technology transfer offices of universities and research institutions to protect their inventions.
- Assisted with evaluation of freedom-to-operate issues for a client in the field of carbon capture.
- Assisted clients with the filing of protest submissions of prior art and re-examination of patents to help ensure their freedom-to-operate.
- Law Society of British Columbia
- Canadian Bar Association
- Intellectual Property Institute of Canada (IPIC)
- Top Reasons to File in Canada
- FOCUS ON MEDICINAL CANNABIS: IP PROTECTION FOR THERAPEUTIC USES
- Patent Term Extension: Now Available in Canada
- Federal Court of Appeal Decision Means Lower Costs for Copyright Owners Seeking the Identity of Alleged Infringers
- 5 Tips for Protecting your Startup’s Intellectual Property
- Got a New Plant Variety? There’s an Act for That!
- Growing Popularity of eSports Raises New Copyright Issues
- Is a Marijuana IP Gold Rush Coming to Canada?
- Can You Stream Your Way Around Copyright Infringement in Canada?
- An Uncertain Prognosis for the Patentability of Diagnostic Methods in Canada
- Canadian Anti-Spam Legislation is Coming Into Force…Are You Ready?
- Canadian Federal Courts Consider When “Prior Use” Invalidates a Patent
- Promises, Promises…An Old Legal Doctrine Poses Difficulty for Canadian Patentees
- Patent Prosecution 2.0 – Third Party Submissions of Prior Art
- Supreme Court of Canada Paves the Way for Generic Version of Viagra™
- Take Advantage of Proposed Changes to Canadian Trade-marks Regulations – Non-Traditional Trade-marks
- A Big Year for Copyright in Canada
- Buonassissi, A.D. and Marles, J.A. “Potential Copyright Liability for the Use of ‘Free’ TV Streaming Devices in Canada”, 2017, 33 CIPR 123.
- Law, G.S., Marles, J.A. “Monsanto v. Schmeiser: patent protection for genetically modified genes and cells in Canada.” Health Law Rev. 2004, 13(1):44-7.
- Marles, J.A., Dahesh, S., Haynes, J., Andrews, B.J., Davidson, A.R. “Protein-protein interaction affinity plays a crucial role in controlling the Sho1p-mediated signal transduction pathway in yeast.” Mol. Cell. 2004, 14(6):813-23.
- Jahn, M., Chen, H., Mullegger, J., Marles, J., Warren, A.J., Withers, S.G. “Thioglycosynthases: double mutant glycosidases that serve as scaffolds for thioglycoside synthesis.” Chem. Commun., 2004, (3):274-5.
- Jahn, M., Marles, J., Warren, R.A., Withers, S.G.. “Thioglycoligases: mutant glycosidases for thioglycoside synthesis.” Angew Chem Int Ed Engl. 2003, 42(3):352-4
Panning for Gold in the Green Rush: IP Protection for the Burgeoning Marijuana Industry
December 8, 2017
Updating your Toolkit for Fighting Obviousness Issues Post-Sanofi
October 12, 2017
Meet you at RESI San Diego 2017
June 19, 2017
Patent Primer for the Life Sciences: Patent Disclosure Requirements
June 8, 2017
Intellectual Property Workshop with Small Business BC
March 24, 2017
Update on Canadian Patent Practice
March 21, 2017
- “Purposively Construing the Boundaries of Patentable Subject Matter in Canada: Diagnostic Methods as an Example”, Canadian Bar Association, BC Branch Intellectual Property & Technology Law Section Meeting – (15 June 2016, Vancouver)
- “IP Law for The Non-IP-Lawyer”, Canadian Bar Association, BC Branch and Victoria Bar Association Meeting – (24 September 2014, Victoria)
- “Balancing Disclosure and Monopoly in Canada–The Promise Doctrine”, Inter-Pacific Bar Association Annual Meeting and Conference – (14 April 2014, Vancouver)
- “Primer on Canada’s New Anti-SPAM Law (CASL)”, Canadian Bar Association, BC Branch – (18 February 2014, Webinar)
- “IP Law for The Non-IP-Lawyer”, Canadian Bar Association, BC Branch – (20 November 2013, Webinar)
- Tutor, Patent Agent Tutorials – Intellectual Property Institute of Canada, 2018
- Member, Intellectual Property Institute of Canada – Patent Practice Committee, 2013-present
- Member, Patent Agent Examination Board, 2014-2016
- Member, Intellectual Property Institute of Canada – Canadian Intellectual Property Office Joint Liaison Committee (Trademarks), 2009-2013